Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study

被引：0
作者：
R Charles Coombes
Christina Angelou
Zamzam Al-Khalili
William Hart
Darius Francescatti
Nicholas Wright
Ian Ellis
Andrew Green
Emad Rakha
Sami Shousha
Hemmel Amrania
Chris C. Phillips
Carlo Palmieri
机构：
[1] Imperial College London,
[2] Rush Medical College,undefined
[3] Barts Cancer Institute,undefined
[4] Nottingham University Hospital,undefined
[5] University of Liverpool,undefined
来源：
Breast Cancer Research and Treatment | 2024年 / 205卷
关键词：
Breast cancer; Prognosis; Mortality; Distant recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 358
页数：9
相关论文
共 50 条
  • [41] Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
    Beomyoung Cho
    Maria Pérez
    Donna B. Jeffe
    Matthew W. Kreuter
    Julie A. Margenthaler
    Graham A. Colditz
    Ying Liu
    [J]. BMC Cancer, 22
  • [42] Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
    Cho, Beomyoung
    Perez, Maria
    Jeffe, Donna B.
    Kreuter, Matthew W.
    Margenthaler, Julie A.
    Colditz, Graham A.
    Liu, Ying
    [J]. BMC CANCER, 2022, 22 (01)
  • [43] Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy
    Elisabeth Sulaica
    Tiffany Han
    Weiqun Wang
    Raksha Bhat
    Meghana V. Trivedi
    Polly Niravath
    [J]. Breast Cancer Research and Treatment, 2016, 157 : 203 - 210
  • [44] Effect of body mass index on the efficacy of adjuvant tamoxifen in premenopausal patients with hormone receptor-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Ozdemir, Nuriye Y.
    Zengin, Nurullah
    Yazici, Ozan
    Sever, Ali R.
    Altundag, Kadri
    [J]. JOURNAL OF BUON, 2016, 21 (01): : 27 - 34
  • [45] The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer
    Ilhan, Rukiye Guler
    Ilhan, Yusuf
    Goksu, Sema Sezgin
    Tatli, Ali Murat
    Coskun, Hasan Senol
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S368 - S372
  • [46] Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential?
    Dediu, M.
    Median, D.
    Alexandru, A.
    Vremes, G.
    Gal, C.
    Gongu, M.
    [J]. JOURNAL OF BUON, 2009, 14 (03): : 375 - 379
  • [47] Mapping the Decision-Making Process for Adjuvant Endocrine Therapy for Breast Cancer: The Role of Decisional Resolve
    Beryl, Louise L.
    Rendle, Katharine A. S.
    Halley, Meghan C.
    Gillespie, Katherine A.
    May, Suepattra G.
    Glover, Jennifer
    Yu, Peter
    Chattopadhyay, Runi
    Frosch, Dominick L.
    [J]. MEDICAL DECISION MAKING, 2017, 37 (01) : 79 - 90
  • [48] Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study
    Arecco, Luca
    Latocca, Maria Maddalena
    Blondeaux, Eva
    Riccardi, Ferdinando
    Mocerino, Carmela
    Guarneri, Valentina
    Mioranza, Eleonora
    Bisagni, Giancarlo
    Gasparini, Elisa
    Puglisi, Fabio
    Membrino, Alexandro
    Ferro, Antonella
    Adamo, Vincenzo
    Giovanardi, Filippo
    Tamberi, Stefano
    Donati, Sara
    Landucci, Elisabetta
    Biganzoli, Laura
    Piccinini, Sara
    Pastorino, Simona
    de Azambuja, Evandro
    Poggio, Francesca
    Lambertini, Matteo
    Del Mastro, Lucia
    [J]. BREAST, 2024, 77
  • [49] A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer
    Bastiaannet, Esther
    Charman, Jackie
    Johannesen, Tom Borge
    Schrodi, Simone
    Siesling, Sabine
    van Eycken, Liesbet
    Walsh, Paul M.
    Audisio, Riccardo A.
    Boelens, Petra G.
    Rubio, Isabel T.
    Jones, Nick
    Lewis, Jan
    van de Velde, Cornelis J. H.
    [J]. CLINICAL BREAST CANCER, 2018, 18 (04) : E613 - E619
  • [50] Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis
    Bell, Robin J.
    Fradkin, Pamela
    Schwarz, Max
    Davis, Susan R.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (01): : 15 - 21
12345